EMPOWER CLINICS INC - EPWCF STOCK NEWS

Empower Clinics Inc. (OTCQB:EPWCF) has announced a business update highlighting its initiatives as COVID-19 testing resumes for cruise ship travelers in Vancouver. The company, the only accredited testing facility near the cruise terminal, expects a surge in demand, with over 1.2 million passengers anticipated this season. Additionally, MediSure launched a Health Canada approved Vitamin D testing kit, shipping 25,000 units to pharmacies. The Medi-Collective has seen over 1,700 patient registrations in Ontario clinics, signaling strong interest in their healthcare services.

Empower Clinics Inc. (OTCQB:EPWCF) has received a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited financial statements for 2021, which were due by May 2, 2022. This MCTO restricts trading for the CEO and CFO until required filings are submitted, although other shareholders can still trade. The company aims to complete these filings by June 30, 2022. Empower plans to comply with National Policy 12-203 by issuing bi-weekly default status reports during this period.

Empower Clinics Inc. announced a delay in filing its annual audited financial statements for the year ended December 31, 2021, initially due by May 2, 2022. The delay is attributed to the auditors' inability to finish the audit, compounded by staff changes at Kai Medical Laboratory. The company has applied for a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC), which, if granted, will allow it to continue operations without affecting all shareholders. Empower aims to submit the required filings by the second half of May 2022.

Empower Clinics Inc (OTCQB:EPWCF) has announced the launch of its Vitamin D Rapid Testing Kit, marking a significant advancement in accessible healthcare. This at-home testing solution will be available through PharmaChoice, which operates over 800 stores in Canada, and will also be sold online and at The Medi-Collective clinics. The kit aims to address the widespread issue of vitamin D deficiency in Canada. Empower's CEO, Steven McAuley, emphasized the company's commitment to providing integrated healthcare solutions.

Empower Clinics Inc (OTCQB:EPWCF) has announced the opening of its 8th clinic, a 3,500 square foot facility in Etobicoke, Ontario, as a flagship for its Medi-Collective brand. This clinic will offer family medicine, tele-dermatology services in partnership with MedX Health Corp, and various paramedical services. The recent launch underscores Empower's commitment to addressing the growing demand for integrated healthcare in Toronto. The company also plans to expand its staff and services in the coming months, enhancing patient care across its clinics.

Empower Clinics Inc (CSE:CBDT)(OTCQB:EPWCF) announced that its three COVID-19 testing sites in Vancouver have achieved DAP certification, confirming compliance with industry best practices. This accreditation, required for COVID-19 testing sites in British Columbia, validates Empower's quality and safety standards. The sites are strategically positioned in high-traffic areas such as Canada Place, catering to increased demand during the upcoming cruise and tourist season. Empower aims to enhance accessibility to COVID-19 testing solutions, including Rapid Antigen and PCR tests.

Empower Clinics Inc. (OTCQB:EPWCF) has launched COVID-19 testing solutions for cruise passengers in Vancouver, marking a significant step in the cruise industry's recovery post-pandemic. This initiative follows an MOU with CERES Terminals Canada, aimed at providing logistical support and testing services. Empower's offerings include Rapid Antigen and Rapid PCR tests available at their clinic and virtually via telehealth. This comprehensive response to the needs of cruise operations highlights Empower's ability to adapt and grow in the evolving healthcare landscape.

Empower Clinics Inc. has successfully closed a non-brokered private placement of unsecured convertible debenture units, raising a total of $2,100,000. Each Unit consists of a 6.0% senior unsecured convertible debenture priced at $1,000 and includes 5,000 common share purchase warrants. The funds will be allocated to growth plans, working capital, and general administrative expenses. Notably, the Company issued fees amounting to $197,000 and provided additional securities to a finder. All issued securities are subject to a hold period of four months.

Empower Clinics (OTCQB: EPWCF) has announced significant growth opportunities in the healthcare sector, particularly for cruise travelers in Vancouver, where an estimated 1.2 million passengers will require COVID-19 testing. The company is focused on becoming a North American leader in integrated healthcare, with strategic efforts including the upcoming acquisition of 8 medical clinics in Ontario, expected to generate $8 million CAD in revenue. Additionally, Empower's Medisure division has achieved record revenues since its acquisition, enhancing the company's at-home testing solutions.